<SEC-DOCUMENT>0001104659-21-119309-index.html : 20210924
<SEC-HEADER>0001104659-21-119309.hdr.sgml : 20210924
<ACCEPTANCE-DATETIME>20210924162111
ACCESSION NUMBER:		0001104659-21-119309
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210923
FILED AS OF DATE:		20210924
DATE AS OF CHANGE:		20210924

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LAPOINTE ANTHONY GREGG
		CENTRAL INDEX KEY:			0001331860

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14778
		FILM NUMBER:		211277570

	MAIL ADDRESS:	
		STREET 1:		PO BOX 83216
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20883-3216

	FORMER NAME:	
		FORMER CONFORMED NAME:	Lapointe Gregg Anthony
		DATE OF NAME CHANGE:	20050630

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOLIGENIX, INC.
		CENTRAL INDEX KEY:			0000812796
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				411505029
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		29 EMMONS DRIVE
		STREET 2:		SUITE B-10
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		609-538-8200

	MAIL ADDRESS:	
		STREET 1:		29 EMMONS DRIVE
		STREET 2:		SUITE B-10
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DOR BIOPHARMA INC
		DATE OF NAME CHANGE:	20020329

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENDOREX CORP
		DATE OF NAME CHANGE:	19960916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2128426-2_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2128426-2_4seq1.html

Document 1 - RAW XML: tm2128426-2_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>